======= AKAP10 ======= == Gene Information == * **Official Symbol**: AKAP10 * **Official Name**: A-kinase anchoring protein 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11216|11216]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43572|O43572]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AKAP10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AKAP10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604694|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the A-kinase anchor protein family. A-kinase anchor proteins bind to the regulatory subunits of protein kinase A (PKA) and confine the holoenzyme to discrete locations within the cell. The encoded protein is localized to mitochondria and interacts with both the type I and type II regulatory subunits of PKA. Polymorphisms in this gene may be associated with increased risk of arrhythmias and sudden cardiac death. [provided by RefSeq, May 2012]. * **UniProt Summary**: Differentially targeted protein that binds to type I and II regulatory subunits of protein kinase A and anchors them to the mitochondria or the plasma membrane. Although the physiological relevance between PKA and AKAPS with mitochondria is not fully understood, one idea is that BAD, a proapoptotic member, is phosphorylated and inactivated by mitochondria-anchored PKA. It cannot be excluded too that it may facilitate PKA as well as G protein signal transduction, by acting as an adapter for assembling multiprotein complexes. With its RGS domain, it could lead to the interaction to G-alpha proteins, providing a link between the signaling machinery and the downstream kinase (By similarity). {ECO:0000250}. |RGS| |protein kinase A binding| |blood coagulation| |coagulation| |hemostasis| |wound healing| |regulation of body fluid levels| |response to wounding| |protein-containing complex| |mitochondrion| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.67| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.48| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.19| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.15| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.75| |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|-1.72| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.78| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.13| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5530 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}